Boston University: Cardiovascular Diseases trials

The registry lists 12 Cardiovascular Diseases studies with Boston University as lead sponsor. 0 are open to participants now and 1 have results posted.

Early Phase 1 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Second eFramngham Heart StudyCompletedNCT04752657Not applicableResults posted
• eFHS Messaging TrialCompletedNCT03516019Not applicable
• Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access InitiativeCompletedNCT02773095Not applicable
• Non-Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study PopulationCompletedNCT02012972
• Effects of Lipemia and Metformin on Endothelial FunctionCompletedNCT01037660Early Phase 1
• ROS Signaling in Endothelial FunctionCompletedNCT01037465Not applicable
• Impact of Gum Infection on Heart DiseaseCompletedNCT00093236Not applicable
• Framingham: Inflammation, Genes & Cardiovascular DiseaseCompletedNCT00083863
• Vascular Function in the Framingham Third GenerationCompletedNCT00035737
• Epidemiological and Genetic Studies of Body Mass IndexCompletedNCT00035698
• Ventricular Matrix Remodeling: Correlates and PrognosisCompletedNCT00021892
• Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCORCompletedNCT00005325